|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 47.32 CNY | -0.80% |
|
+0.87% | -4.50% |
| Jan. 22 | Shenzhen Salubris Pharmaceuticals Gets Director Approval for Hong Kong Secondary Listing | MT |
| Jan. 22 | China Stocks Gain After Trump Backs Down on Europe Tariffs; Salubris Closes 4% Lower | MT |
| Capitalization | 52.75B 7.6B 6.44B 5.9B 5.59B 10.37B 689B 10.84B 68.54B 27.14B 332B 28.51B 27.92B 1,194B | P/E ratio 2025 * |
78.6x | P/E ratio 2026 * | 66.8x |
|---|---|---|---|---|---|
| Enterprise value | 52.75B 7.6B 6.44B 5.9B 5.59B 10.37B 689B 10.84B 68.54B 27.14B 332B 28.51B 27.92B 1,194B | EV / Sales 2025 * |
11.8x | EV / Sales 2026 * | 9.78x |
| Free-Float |
37.38% | Yield 2025 * |
1.14% | Yield 2026 * | 1.25% |
| 1 day | -0.80% | ||
| 1 week | +0.87% | ||
| Current month | +0.87% | ||
| 1 month | -7.94% | ||
| 3 months | -18.99% | ||
| 6 months | -1.33% | ||
| Current year | -4.50% |
| 1 week | 44.95 |  | 48.8 |
| 1 month | 44.95 | | 56.17 |
| Current year | 44.95 | | 56.17 |
| 1 year | 27.66 | | 65.63 |
| 3 years | 23.5 | | 65.63 |
| 5 years | 20 | | 65.63 |
| 10 years | 16.7 | | 65.63 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jie Yan
CEO | Chief Executive Officer | 53 | 2022-09-22 |
Yun Kong
DFI | Director of Finance/CFO | 53 | 2021-12-29 |
Jian Feng Yang
ADM | Chief Administrative Officer | 50 | 2005-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Cheng Hai Ye
CHM | Chairman | 82 | 1998-11-02 |
Sing Ye
CHM | Chairman | 51 | 2022-09-22 |
Jian Feng Yang
BRD | Director/Board Member | 50 | 2010-08-19 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.80% | +0.87% | +58.79% | +26.49% | 7.6B | |
| -0.44% | +6.26% | -3.13% | +68.43% | 44.89B | |
| -1.46% | +1.11% | +17.89% | +128.57% | 31.43B | |
| -0.25% | +0.45% | -9.66% | +28.96% | 11.86B | |
| -1.86% | +0.32% | -10.66% | +85.24% | 9.86B | |
| -0.86% | +0.43% | +40.43% | +124.27% | 8.31B | |
| +0.70% | +4.06% | +148.76% | +839.85% | 7.95B | |
| +0.81% | +7.90% | +61.65% | -12.13% | 7.44B | |
| -.--% | +0.14% | - | - | 6.79B | |
| +1.32% | +6.59% | +9.86% | +42.79% | 6.55B | |
| Average | -0.28% | +3.51% | +34.88% | +148.05% | 14.27B | |
| Weighted average by Cap. | -0.56% | +3.67% | +19.80% | +120.66% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 4.48B 645M 546M 501M 474M 880M 58.45B 920M 5.82B 2.3B 28.14B 2.42B 2.37B 101B | 5.39B 777M 658M 603M 571M 1.06B 70.41B 1.11B 7.01B 2.77B 33.9B 2.91B 2.85B 122B |
| Net income | 667M 96.1M 81.35M 74.56M 70.61M 131M 8.71B 137M 866M 343M 4.19B 360M 353M 15.09B | 776M 112M 94.68M 86.77M 82.18M 153M 10.13B 160M 1.01B 399M 4.88B 419M 411M 17.56B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-02-06 | 47.32 ¥ | -0.80% | 6,878,850 |
| 26-02-05 | 47.70 ¥ | -0.93% | 5,515,493 |
| 26-02-04 | 48.15 ¥ | +4.27% | 11,799,840 |
| 26-02-03 | 46.18 ¥ | +1.21% | 7,130,513 |
| 26-02-02 | 45.63 ¥ | -2.73% | 7,650,375 |
End-of-day quote Shenzhen S.E., February 05, 2026
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Annual profits - Rate of surprise
- Stock Market
- Equities
- 002294 Stock
Select your edition
All financial news and data tailored to specific country editions
